| SC 13G | 2019-12-18 | Iroquois Capital Management, LLC | Akers Biosciences, Inc. | 88,000 | 10.0% | EDGAR |
| SC 13G | 2019-12-13 | ARMISTICE CAPITAL, LLC | Akers Biosciences, Inc. | 190,714 | 10.0% | EDGAR |
| SC 13G/A | 2019-12-11 | ALPHA CAPITAL ANSTALT | Akers Biosciences, Inc. | 113,570 | 10.0% | EDGAR |
| SC 13G/A | 2019-01-30 | Hudson Bay Capital Management LP | Akers Biosciences, Inc. | 45,262 | 0.4% | EDGAR |
| SC 13G/A | 2019-01-10 | Empery Asset Management, LP | Akers Biosciences, Inc. | 239,914 | 1.9% | EDGAR |
| SC 13G/A | 2018-07-26 | ALPHA CAPITAL ANSTALT | Akers Biosciences, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2018-05-07 | BIGGER CAPITAL FUND L P | Akers Biosciences, Inc. | 100,000 | - | EDGAR |
| SC 13G/A | 2018-02-13 | BIGGER CAPITAL FUND L P | Akers Biosciences, Inc. | 1,953,006 | 6.2% | EDGAR |
| SC 13G | 2018-02-01 | Hudson Bay Capital Management LP | Akers Biosciences, Inc. | 4,216,831 | 10.0% | EDGAR |
| SC 13G/A | 2018-01-18 | Empery Asset Management, LP | Akers Biosciences, Inc. | 913,257 | 8.6% | EDGAR |
| SC 13G | 2018-01-02 | BIGGER CAPITAL FUND L P | Akers Biosciences, Inc. | 2,500,000 | 8.0% | EDGAR |
| SC 13G | 2017-12-22 | ALPHA CAPITAL ANSTALT | Akers Biosciences, Inc. | 2,516,635 | 9.9% | EDGAR |
| SC 13G | 2017-04-07 | Empery Asset Management, LP | Akers Biosciences Inc | 724,200 | 8.4% | EDGAR |
| SC 13G/A | 2016-01-25 | ACT Capital Management, LLLP | Akers Biosciences Inc | 213,500 | 3.9% | EDGAR |
| SC 13G/A | 2015-01-23 | ACT Capital Management, LLLP | Akers Biosciences Inc | 378,500 | 7.3% | EDGAR |
| SC 13G | 2014-02-25 | ACT Capital Management, LLLP | Akers Biosciences Inc | 280,100 | 5.7% | EDGAR |
| SC 13D | 2014-02-18 | Knox Thomas J | Akers Biosciences Inc | - | 7.3% | EDGAR |